bourva
ASX · ASX Health Care CSL

CSL Limited share price

CSL · CSL Limited
A$240.00 ▼ A$3.69 · -1.51%
After hours · 23:26 local Jun 26, 2026 Prices delayed ≥15 min Sample data

Price chart

Key statistics

Market cap
A$115.92B
P/E (TTM)
30.0×
EPS (TTM)
A$8.00
Dividend yield
3.66%
52-week range
A$181.08 – A$248.50
Avg volume
1.3M
Beta
0.97
Prev close
A$243.69

About CSL Limited

AI-assisted summary

CSL Limited (CSL) is a company listed on ASX in the Health Care sector. This page summarises its share price, key statistics, dividends and fundamentals using delayed and sample data — figures may differ from official sources.

Dividend history

Annual payout (TTM): A$8.79 · Forward yield: 3.66%
Ex-date Pay date Amount Frequency Dividend yield
Jun 21, 2026 Jun 28, 2026 A$3.85 Semi-annual 3.21%
Dec 20, 2025 Dec 27, 2025 A$4.94 Semi-annual 4.12%
Jun 20, 2025 Jun 27, 2025 A$4.76 Semi-annual 3.97%
Dec 19, 2024 Dec 26, 2024 A$5.15 Semi-annual 4.29%

Financials

Annual figures, last 5 fiscal years.

Date Revenue Net income EPS (TTM) P/E (TTM)
FY2024 A$91.05B A$7.70B A$5.95 35.6×
FY2023 A$76.29B A$16.58B A$6.54 28.0×
FY2022 A$63.99B A$4.99B A$7.11 32.0×
FY2021 A$58.72B A$4.26B A$7.84 28.1×
FY2020 A$53.49B A$12.79B A$8.26 34.9×

Stock splits

No stock splits on record for CSL Limited.

Analyst forecast

12-month price target
A$229.79
Consensus rating
Sell
Implied upside
-4.25%
Based on 28 analysts
12-month

Aggregated analyst estimates (sample)

Related

Frequently asked questions

What is the current CSL Limited share price?

CSL Limited (CSL) last traded at A$240.00, as of Jun 26, 2026. Prices on bourva are delayed and shown for reference only.

Does CSL Limited pay a dividend?

Yes — CSL Limited has a forward dividend yield of about 3.66%, based on its trailing 12-month payout.

What is CSL Limited's market capitalisation?

CSL Limited has an approximate market capitalisation of A$115.92B.

What is CSL Limited's P/E ratio?

CSL Limited trades at a trailing P/E ratio of about 30.0.

Compare with another ticker
See two tickers side by side — price, valuation and dividends.